18
38M
17
1.64
3
0.06
8
- Areas of investment
Summary
The main department of described VC is located in the Deerfield. The fund was located in North America if to be more exact in United States. Baxter Ventures seemed to be an CVC arrangement as part of the organization.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. Comparing to the other companies, this Baxter Ventures performs on 18 percentage points more the average number of lead investments. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2015. The top activity for fund was in 2015.
We also calculated 2 valuable employees in our database.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Medical Device, Fitness. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight VitalConnect, Covagen, SANIFIT.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Baxter Ventures, startups are often financed by Warburg Pincus, The Vertical Group, Perceptive Advisors. The meaningful sponsors for the fund in investment in the same round are Andera Partners, Sante Ventures, SR One. In the next rounds fund is usually obtained by SR One, OrbiMed, MPM Capital.
Investments analytics
Analytics
- Total investments
- 18
- Lead investments
- 3
- Exits
- 8
- Rounds per year
- 1.64
- Follow on index
- 0.06
- Investments by industry
- Health Care (14)
- Biotechnology (12)
- Therapeutics (6)
- Medical (5)
- Medical Device (4) Show 17 more
- Investments by region
-
- United States (13)
- Iceland (1)
- Switzerland (1)
- Spain (1)
- Israel (1) Show 1 more
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 138M
- Group Appearance index
- 0.94
- Avg. company exit year
- 7
- Avg. multiplicator
- 2.17
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Kit Check | 20 Jun 2016 | Software, Information Technology, Health Care, Enterprise Software | Late Stage Venture | 20M | United States, District of Columbia, Washington |
| VitalConnect | 31 Oct 2017 | Biotechnology, Analytics, Health Care, Medical Device, Wearables | Late Stage Venture | 38M | United States, California, San Jose |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.